GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioiasis AD (XBUL:BIOA) » Definitions » Research & Development

Bioiasis AD (XBUL:BIOA) Research & Development : лв0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Bioiasis AD Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bioiasis AD's Research & Development for the three months ended in Mar. 2024 was лв0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was лв0.00 Mil.

Bioiasis AD Research & Development Historical Data

The historical data trend for Bioiasis AD's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioiasis AD Research & Development Chart

Bioiasis AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bioiasis AD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bioiasis AD Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioiasis AD  (XBUL:BIOA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bioiasis AD Research & Development Related Terms

Thank you for viewing the detailed overview of Bioiasis AD's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioiasis AD (XBUL:BIOA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioiasis AD (XBUL:BIOA) » Definitions » Research & Development
Comparable Companies
OSTO:ACARIX XTAE:BIOV DRAD OSTO:EPIS B SGX:546 HLTY TSE:5212 ASX:SVA XKRX:285770 ALRT XSAT:IMS ASX:AZV XTAE:MDGS LSE:DEMG MYO NAOV ASX:ADO ASX:AMT ASX:UCM ASX:CDX
Traded in Other Exchanges
N/A
Address
60, Deyan Belishki Str., Ground Floor, Sofia, BGR, 1404
Website
http://www.bioiasis.com
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.

Bioiasis AD (XBUL:BIOA) Headlines

No Headlines